JAKARTA, Jan 14 (Reuters) – Indonesia has approved Merck & Co Inc's (MRK.N) COVID-19 antiviral pill molnupiravir for emergency use, the country's food and drug agency said in a statement.
A batch of 400,000 pills had arrived in Indonesia, health minister Budi Gunadi Sadikin said this week. The pill was jointly developed by U.S.-based Merck and Ridgeback Biotherapeutics.
Register now for FREE unlimited access to Reuters.comRegisterReporting by Stanley Widianto
Editing by Ed Davies